CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasui, Y.
Right arrow Articles by Daling, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasui, Y.
Right arrow Articles by Daling, J.
Cancer Epidemiology Biomarkers & Prevention Vol. 10, 9-16, January 2001
© 2001 American Association for Cancer Research


Hypothesis

Breast Cancer Risk and "Delayed" Primary Epstein-Barr Virus Infection

Yutaka Yasui1, John D. Potter, Janet L. Stanford, Mary Anne Rossing, Marcy D. Winget, Mary Bronner and Janet Daling

Cancer Prevention Research Program [Y. Y., J. D. P., M. D. W.], and Epidemiology Program [J. L. S., M. A. R., J. D.], Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024; and Department of Pathology, University of Washington, Seattle, Washington 98103 [M. B.]

Parallel to its established causal association with both infectious mononucleosis (IM) and young adulthood Hodgkin disease (YAHD), we propose a hypothesis that "delayed" primary EBV infection (i.e., primary infection occurring during adolescence or adulthood) is associated with elevated breast cancer risk. We evaluated this hypothesis with two investigations, one descriptive and the other analytic. The descriptive study used international/United States cancer registry data to assess the association between incidence rates of breast cancer and those of YAHD. The incidence rates of the seemingly unrelated neoplasms were strongly correlated (correlation coefficients of 0.74 and 0.88 for international and United States data, respectively; these were higher than the correlation coefficients of YAHD with two other cancers that we considered). Populations with higher incidence rates corresponded to those with higher likelihood of delayed primary EBV infection. The analytical study was based on a population-based case-control study of breast cancer in middle-aged women. Age-adjusted odds ratios of breast cancer in women who reported a history of IM, relative to women who did not, increased monotonically from 0.55 [95% confidence interval (CI), 0.05–6.17] for women with 0–9 years of age at IM onset to 2.67 (CI, 1.04–6.89) for women with >=25 years of age at IM onset (P = 0.016). An older age at tonsillectomy, another surrogate of delayed EBV exposure, was also associated with increased risk of breast cancer: odds ratios, 0.92 (CI, 0.57–1.48) and 1.76 (CI, 1.15–2.69) for women with tonsillectomy at 0–4 years of age and >=15 years of age, respectively (P = 0.018). Adjusting for additional potential confounders did not modify the associations appreciably. The implications of the findings and a potential biological mechanism are presented.




This article has been cited by other articles:


Home page
Stat Methods Med ResHome page
A. R Dabney and J. C Wakefield
Issues in the mapping of two diseases
Statistical Methods in Medical Research, February 1, 2005; 14(1): 83 - 112.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. L. Glaser, J. L. Hsu, and M. L. Gulley
Epstein-Barr Virus and Breast Cancer: State of the Evidence for Viral Carcinogenesis
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 688 - 697.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. Krieger, E. F. Strong, C. Makosky, and J. Weuve
Breast Cancer, Birth Cohorts, and Epstein-Barr Virus: Methodological Issues in Exploring the "Hygiene Hypothesis" in Relation to Breast Cancer, Hodgkin's Disease, and Stomach Cancer
Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 405 - 411.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. G. Murray, D. Lissauer, J. Junying, G. Davies, S. Moore, A. Bell, J. Timms, D. Rowlands, C. McConkey, G. M. Reynolds, et al.
Reactivity with A Monoclonal Antibody to Epstein-Barr Virus (EBV) Nuclear Antigen 1 Defines a Subset of Aggressive Breast Cancers in the Absence of the EBV Genome
Cancer Res., May 1, 2003; 63(9): 2338 - 2343.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. L. Glaser
Correspondence re: Yasui et al., Breast Cancer Risk and "Delayed" Primary Epstein-Barr Virus Infection. 10: 9-16, 2001
Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 73 - 73.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Yasui and J. D. Potter
Reply
Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 74 - 74.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Titus-Ernstoff, K. M. Egan, P. A. Newcomb, J. Ding, A. Trentham-Dietz, E. R. Greenberg, J. A. Baron, D. Trichopoulos, and W. C. Willett
Early Life Factors in Relation to Breast Cancer Risk in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., February 1, 2002; 11(2): 207 - 210.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.